UBS Group’s Advantest Corp ATE Stock Holding History

UBS Group’s Portfolio ATE Stock Details ATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,296	Closed	-$31K	–	8332
2016 Q1	$31K	Buy	3,296 +3,199	+3,298%	+$28.6K	﹤0.01%	5877
2015 Q4	$1K	Sell	97 -4,738	-98%	-$39.8K	﹤0.01%	8253
2015 Q3	$35K	Buy	4,835 +4,773	+7,698%	+$41.3K	﹤0.01%	6164
2015 Q2	$1K	Buy	+62	New	+$725	﹤0.01%	8391
2015 Q1	–	Sell	-189	Closed	-$2K	–	9900
2014 Q4	$2K	Buy	+189	New	+$2.27K	﹤0.01%	9484

Other funds holding ATE

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

WAM

World Asset Management Detroit, Michigan $1.01B AUM 42.4% 1-Year Est. Return

CIM

Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return

CCA

Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return

UBS Group's ATE Position: Q2 2016 in Review

UBS Group sold out of Advantest Corp (ATE) in Q2 2016, closing a stake of 3,296 shares — an estimated $31K sold.

UBS Group first reported a position in ATE in Q4 2014 and held it in 5 quarters. The position peaked at $35K in Q3 2015. 5 funds tracked by Wall St. Rank hold ATE as of Q2 2016.

UBS Group reported no remaining Advantest Corp position as of Q2 2016 after selling out during the quarter.
UBS Group sold 3,296 Advantest Corp shares in Q2 2016, an estimated $31K.
UBS Group first reported a position in Advantest Corp in Q4 2014 and held it in 5 quarters.
UBS Group's Advantest Corp position peaked at $35K in Q3 2015.
5 funds tracked by Wall St. Rank held Advantest Corp as of Q2 2016.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.